Literature DB >> 1459264

In vitro lymphocyte activity in women with endometriosis--an altered immune response?

S M Gilmore1, S Aksel, C Hoff, R D Peterson.   

Abstract

OBJECTIVE: To determine the possible role of the immune system in the pathogenesis of endometriosis.
DESIGN: The lymphocyte proliferative response in the presence of autologous endometrial cells was assayed by tritiated thymidine incorporation.
SETTING: Patients were recruited from a university outpatient clinic. MAIN OUTCOME MEASURE: To determine the lymphocyte proliferative response to endometrium in controls and patients with endometriosis. PARTICIPANTS: Twenty patients with endometriosis and 26 control women were studied.
RESULTS: The lymphocyte proliferative response in the presence of autologous endometrium was significantly lower in women with endometriosis when compared with controls.
CONCLUSION: This study indicates that an altered lymphocyte/endometrial cell relationship is operational in women with endometriosis and may contribute to the pathogenesis of the disease.

Entities:  

Mesh:

Year:  1992        PMID: 1459264

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

1.  Differential expression of microRNAs between eutopic and ectopic endometrium in ovarian endometriosis.

Authors:  Nicoletta Filigheddu; Ilaria Gregnanin; Paolo E Porporato; Daniela Surico; Beatrice Perego; Licia Galli; Claudia Patrignani; Andrea Graziani; Nicola Surico
Journal:  J Biomed Biotechnol       Date:  2010-03-10

Review 2.  Immunological aspects of endometriosis: a review.

Authors:  Milena Králíčková; Vaclav Vetvicka
Journal:  Ann Transl Med       Date:  2015-07

Review 3.  Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target.

Authors:  Chiara Agostinis; Andrea Balduit; Alessandro Mangogna; Gabriella Zito; Federico Romano; Giuseppe Ricci; Uday Kishore; Roberta Bulla
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.